Zenith Epigenetics – bromodomain inhibitors

Zenith Epigenetics is a biotech company developing bromodomain (BET) inhibitors for the treatment of cancer and autoimmune disorders. Zenith Epigenetics aims to become a leading epigenetic company translating bromodomain biology into impactful therapies.

Zenith Epigenetics – bromodomain inhibitors

Zenith Epigenetics

Continue reading